From: Using automated electronic medical record data extraction to model ALS survival and progression
KUMC | |
---|---|
Number of patients | 352 |
Percent female / Male | 43/ 57 |
Percent Caucasian / Non-Caucasian | 89/ 11 |
Percent limb onset / Bulbar / Other | 65/ 27/ 8 |
Percent using riluzole Yes / No / NA | 63/ 35 / 2 |
Percent survived during follow up | 69 |
Median time from baseline to last record, months (IQR) | 7.1 (17.7) |
Median age at baseline (IQR) | 65.3 (11.2) |
Median number of months from onset to baseline (IQR) | 19.0 (28.1) |
Median baseline FVC percent predicted (IQR) | 70.0 (32.5) |
Median BMI at baseline (IQR) | 26.4 (7.23) |
Median number of ALSFRS-R assessments (IQR) | 3 (4) |
Median baseline ALSFRS-R (SD) | 35.5 (10.0) |